NAMPT is an enzyme for the NAD+ biosynthetic salvage pathway and is overexpressed in cancers. Combination of NAMPT inhibitor and cisplatin inhibited expression of ALDH1 and CD133 OCSCs and improved survival in the mouse model. This evidence concerns the gene PROM1 and cancer.